Ex-White House Drug Czar McCaffrey, U.S. Congress Drug Caucus Chair Cummings, CRC Health CEO Karlin Join Hopkins Researchers at News Conference April 17 on Breakthrough Study: Internet Video Drug Treatment as Effective as Traditional Counseling
BALTIMORE , FRI., APRIL 17, 10AM , INSTITUTES FOR BEHAVIOR RESOURCES, 2104 MARYLAND AVE.
Demonstration During Event ; Major New Tool to Reach Additional Victims
BALTIMORE, April 13 /PRNewswire-USNewswire/ -- Four-Star General Barry McCaffrey, the former W...
4-Star Gen. Barry McCaffrey, Former U.S. Drug Czar, & Country's Top Drug Treatment CEO Barry Karlin to Keynote Palm Beach, FL National 'Moment Of Change' Intervention Conference:
8:30-10 AM MON. OCT. 1, BREAKERS HOTEL, 1 S. County Road, Palm Beach, OPEN TO MEDIA; Also Press Availability Following, at 10 AM
McCaffrey, now West Point professor, and Karlin
to Discuss 'The Future of National Drug Policy, Intervention, and Addiction Treatment':
23 Million Need T...
SignatureForum Reveals Top-Rated Cosmetic Surgeons in US
...ra, FL (9.13)
Dr. Jourdan Gottlieb - Seattle, WA (8.99)
Dr. Arnold Breitbart - Manhasset, NY (8.93)
Dr. Jan karlin
- Orlando, FL (8.93)
Dr. David Broadway - Lone Tree, CO (8.86)
Dr. Brian Joseph - Winter Park, FL (8.48)
Dr. Charles Wallace - Dallas, TX ...
CRC Health Group Announces Acquisition of Durham's Structure House, Weight Loss Facility
...ther location on the West Coast. "We are extremely pleased
that Dr. Musante has agreed to continue in his current leadership role at
Structure House," karlin
added. "His dedication to achieving the highest
standards of quality has earned the facility a reputation for excellence in
the field of weight manage...
4-Star Gen. Barry McCaffrey, Former U.S. Drug Czar, to Address National Drug Crisis, Keynote Grand Opening of New Allenwood, PA 'National Model' Detox Center
...ania Treatment Gap of One Million Needing Treatment vs. 90,000 Obtaining Help
WDR Parent CRC Health Group CEO Dr. Barry karlin
to Join State & Local Officials, State Representatives
HARRISBURG, Pa., Sept. 3 /PRNewswire-USNewswire/ -- Four-Star General
4-Star Gen. Barry Mccaffrey, Former U.S. Drug Czar, to Keynote 'Recovery Happens!' Rally for Treatment: Wed., Sept. 5, 11 Am, State Capitol West Steps, Sacramento
...ganizers of the
event. -- Keynote, Gen. Barry McCaffrey: 11:30 AM, Wednesday, September 5,
West Steps of the State Capitol. General McCaffrey and Dr. karlin
be available to the press immediately following the keynote address, at
press tent south of stage. -- Media are also welcome to attend and ...
CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
...Regions. We are extremely pleased that
the executive team that helped build this outstanding program will continue
in their current leadership roles," karlin
added. Founded by Perry Litchfield in 2004, Bayside Marin has established a
national reputation for excellence. "Our commitment to excellence has nev...
Poniard to Present Clinical Data From Picoplatin Trials in Multiple Tumor Types at American Society of Clinical Oncology 2008 Annual Meeting
...tate cancer (HRPC) Roman L, Karlov P, Cheporov S, Lopatkin N, Breitz H, karlin
D, Baker G. General Poster Session: Saturday, May 31, from 8 a.m. to 12...erapy for colorectal cancer Cheporov S, Gladkov O, Biakhov M, Breitz H, karlin
D, Baker G. General Poster Session: Monday, June 2, from 8 a.m. to 12 p...
Poniard Pharmaceuticals' Oral Picoplatin Demonstrates Positive Bioavailability in Ongoing Phase 1 Trial
...All Rights Reserved.
Poniard and Poniard Pharmaceuticals are trademarks of Poniard
Abstract #209. Yee L, Sharma S, Breitz H, karlin
D, Phillips A, Houston
S, Saleh M. A phase 1 randomized crossover oral picoplatin bioavailability
pharmacokinetics and pharmacodynamics study. To be p...
Poniard Pharmaceuticals Announces Clinical Data From Picoplatin Oral Phase 1 to Be Presented at the American Association of Cancer Research Annual Meeting
...n bioavailability pharmacokinetics and pharmacodynamics study.
Abstract #209, Session ID: Clinical Research 1; Yee L, Sharma S, Breitz H, karlin
D, Phillips A, Houston S, Saleh M. General Poster Session Sunday April 13, 8:00 AM PT.
-- Picoplatin overcomes resistance in small cell lung ca...
Poniard Pharmaceuticals Announces Clinical Data from Picoplatin
Phase 2 Small Cell Lung Cancer Trial To Be Presented at American
Society of Clinical Oncology Annual Meeting
leucovorin as initial therapy in subjects with metastatic colorectal
Gladkov Jr O, Manikhas G, Biakhov M, Tjulandin S, karlin
-- Abstract #15546
Phase 1 study of picoplatin and docetaxel with prednisone in patients
with chemotherapy-naive metastatic h...
Poniard Pharmaceuticals Announces Promising Data From Interim
Safety Analysis of Phase 1 Combination Trials of Picoplatin in
Colorectal and Prostate Cancers
...n Society of Clinical Oncology (ASCO) Annual Meeting
-- Abstract #14510. Gladkov Jr O, Manikhas G, Biakhov M, Tjulandin S,
D. Phase 1 study of picoplatin in combination with 5-
fluorouracil and leucovorin as initial therapy in subjects with